Brain Receptor Mosaics and Their Intramembrane Receptor-Receptor Interactions: Molecular Integration in Transmission and Novel Targets for Drug Development

Agnati, 1980, Aspects on receptor regulation and isoreceptor identification, Med Biol, 58, 182 Fuxe, 1983, Evidence for the ex istence of receptor-receptor interactions in the central nervous system. Studies on the regulation of monoamine receptors by neuropeptides, J Neural Transm Suppl, 18, 165 Fuxe, 1981, Modulation by cholecystokinins of 3H-spiroperidol binding in rat striatum: evidence for increased affinity and reduction in the number of binding sites, Acta Physiol Scand, 113, 567, 10.1111/j.1748-1716.1981.tb06942.x Limbird, 1975, Beta-adrenergic receptors: evidence for negative cooperativity, Biochem Biophys Res Commun, 64, 1160, 10.1016/0006-291X(75)90815-3 Agnati, 1982, New vistas on synaptic plasticity: the receptor mosaic hypothesis of the engram, Med Biol, 60, 183 Zoli, 1993, Receptor-receptor interactions as an integrative mechanism in nerve cells, Mol Neurobiol, 7, 293, 10.1007/BF02769180 Fuxe, 1998, Integrated events in central dopamine transmission as analyzed at multiple levels. Evidence for intramembrane adenosine A2A/dopamine D2 and adenosine A1/dopamine D1 receptor interactions in the basal ganglia, Brain Res Brain Res Rev, 26, 258, 10.1016/S0165-0173(97)00049-0 Fuxe, 2007, Intramembrane receptor-receptor interactions: a novel principle in molecular medicine, J Neural Transm, 114, 49, 10.1007/s00702-006-0589-0 Diaz-Cabiale, 2007, Receptor-receptor interactions in central cardiovascular regulation. Focus on neuropeptide/alpha(2)-adrenoreceptor interactions in the nucleus tractus solitarius, J Neural Transm, 114, 115, 10.1007/s00702-006-0559-6 Agnati, 2003, Molecular mechanisms and therapeutical implications of intramembrane receptor/receptor interactions among heptahelical receptors with examples from the striatopallidal GABA neurons, Pharmacol Rev, 55, 509, 10.1124/pr.55.3.2 Agnati, 2005, How proteins come together in the plasma membrane and function in macro-molecular assemblies: focus on receptor mosaics, J Mol Neurosci, 26, 133, 10.1385/JMN:26:2-3:133 Angers, 2001, Biochemical and biophysical demonstration of GPCR oligomerization in mammalian cells, Life Sci, 68, 2243, 10.1016/S0024-3205(01)01012-8 Filizola, 2005, The structure and dynamics of GPCR oligomers: a new focus in models of cell-signaling mechanisms and drug design, Curr Opin Drug Discov Devel, 8, 577 Fuxe, 2008, Receptor-receptor interactions within receptor mosaics. Impact on neuropsychopharmacology, Brain Res Rev, 58, 15, 10.1016/j.brainresrev.2007.11.007 George, 2002, G-protein-coupled receptor oligomerization and its potential for drug discovery, Nat Rev Drug Discov, 1, 808, 10.1038/nrd913 Javitch, 2004, The ants go marching two by two: oligomeric structure of G-protein-coupled receptors, Mol Pharmacol, 66, 1077, 10.1124/mol.104.006320 Maggio, 2005, The impact of G-protein-coupled receptor hetero-oligomerization on function and pharmacology, Febs J, 272, 2939, 10.1111/j.1742-4658.2005.04729.x Milligan, 2001, Oligomerisation of G-protein-coupled receptors, J Cell Sci, 114, 1265, 10.1242/jcs.114.7.1265 Milligan, 2004, G protein-coupled receptor dimerization: function and ligand pharmacology, Mol Pharmacol, 66, 1, 10.1124/mol.104.000497. Milligan, 2007, Allosteric modulation of heterodimeric G-protein-coupled receptors, Trends Pharmacol Sci, 28, 615, 10.1016/j.tips.2007.11.001 Prinster, 2005, Heterodimerization of G protein-coupled receptors: specificity and functional significance, Pharmacol Rev, 57, 289, 10.1124/pr.57.3.1 Terrillon, 2004, Roles of G-protein-coupled receptor dimerization, EMBO Rep, 5, 30, 10.1038/sj.embor.7400052 Simons, 1997, Functional rafts in cell membranes, Nature, 387, 569, 10.1038/42408 Hullin-Matsuda, 2007, Monitoring the distribution and dynamics of signaling microdomains in living cells with lipid-specific probes, Cell Mol Life Sci, 64, 2492, 10.1007/s00018-007-7281-x Canals, 2003, Adenosine A2A-dopamine D2 receptor-receptor heteromerization: qualitative and quantitative assessment by fluorescence and bioluminescence energy transfer, J Biol Chem, 278, 46741, 10.1074/jbc.M306451200 Genedani, 2005, Computer-assisted image analysis of caveolin-1 involvement in the internalization process of adenosine A2A-dopamine D2 receptor heterodimers, J Mol Neurosci, 26, 177, 10.1385/JMN:26:2-3:177 Kurzchalia, 1999, Membrane microdomains and caveolae, Curr Opin Cell Biol, 11, 424, 10.1016/S0955-0674(99)80061-1 Maggio, 1993, Coexpression studies with mutant muscarinic/adrenergic receptors provide evidence for inter-molecular “cross-talk” between G-protein-linked receptors, Proc Natl Acad Sci USA, 90, 3103, 10.1073/pnas.90.7.3103 Monnot, 1996, Polar residues in the transmembrane domains of the type 1 angiotensin II receptor are required for binding and coupling. Reconstitution of the binding site by co-expression of two deficient mutants, J Biol Chem, 271, 1507, 10.1074/jbc.271.3.1507 Gouldson, 2000, Dimerization and domain swapping in G-protein-coupled receptors: a computational study, Neuropsychopharmacology, 23, S60, 10.1016/S0893-133X(00)00153-6 Hebert, 1996, A peptide derived from a beta2-adrenergic receptor transmembrane domain inhibits both receptor dimerization and activation, J Biol Chem, 271, 16384, 10.1074/jbc.271.27.16384 Romano, 1996, Metabotropic glutamate receptor 5 is a disulfide-linked dimer, J Biol Chem, 271, 28612, 10.1074/jbc.271.45.28612 Ng, 1996, Dopamine D2 receptor dimers and receptor-blocking peptides, Biochem Biophys Res Commun, 227, 200, 10.1006/bbrc.1996.1489 Marshall, 2005, Is the GABA B heterodimer a good drug target?, J Mol Neurosci, 26, 169, 10.1385/JMN:26:2-3:169 Marshall, 1999, GABAB receptors—the first 7TM heterodimers, Trends Pharmacol Sci, 20, 396, 10.1016/S0165-6147(99)01383-8 Margeta-Mitrovic, 2000, A trafficking checkpoint controls GABA(B) receptor heterodimerization, Neuron, 27, 97, 10.1016/S0896-6273(00)00012-X Pagano, 2001, C-terminal interaction is essential for surface trafficking but not for heteromeric assembly of GABA(b) receptors, J Neurosci, 21, 1189, 10.1523/JNEUROSCI.21-04-01189.2001 White, 1998, Heterodimerization is required for the formation of a functional GABA(B) receptor, Nature, 396, 679, 10.1038/25354 Kaupmann, 1998, GABA(B)-receptor subtypes assemble into functional heteromeric complexes, Nature, 396, 683, 10.1038/25360 Jordan, 1999, G-protein-coupled receptor heterodimerization modulates receptor function, Nature, 399, 697, 10.1038/21441 Gines, 2000, Dopamine D1 and adenosine A1 receptors form functionally interacting heteromeric complexes, Proc Natl Acad Sci USA, 97, 8606, 10.1073/pnas.150241097 AbdAlla, 2000, AT1-receptor heterodimers show enhanced G-protein activation and altered receptor sequestration, Nature, 407, 94, 10.1038/35024095 Milligan, 2005, Methods to monitor the quaternary structure of G protein-coupled receptors, Febs J, 272, 2914, 10.1111/j.1742-4658.2005.04731.x Park, 2004, Oligomeric potential of the M2 muscarinic cholinergic receptor, J Neurochem, 90, 537, 10.1111/j.1471-4159.2004.02536.x Woods, 2005, Role of electrostatic interaction in receptor-receptor heteromerization, J Mol Neurosci, 26, 125, 10.1385/JMN:26:2-3:125 Jares-Erijman, 2006, Imaging molecular interactions in living cells by FRET microscopy, Curr Opin Chem Biol, 10, 409, 10.1016/j.cbpa.2006.08.021 Zimmermann, 2002, Spectral imaging and linear un-mixing enables improved FRET efficiency with a novel GFP2-YFP FRET pair, FEBS Lett, 531, 245, 10.1016/S0014-5793(02)03508-1 Milligan, 2004, Applications of bioluminescence- and fluorescence resonance energy transfer to drug discovery at G protein-coupled receptors, Eur J Pharm Sci, 21, 397, 10.1016/j.ejps.2003.11.010 Rocheville, 2000, Receptors for dopamine and somatostatin: formation of hetero-oligomers with enhanced functional activity, Science, 288, 154, 10.1126/science.288.5463.154 Canals, 2004, Homodimerization of adenosine A2A receptors: qualitative and quantitative assessment by fluorescence and bioluminescence energy transfer, J Neurochem, 88, 726, 10.1046/j.1471-4159.2003.02200.x McVey, 2001, J Biol Chem, 276, 14092, 10.1074/jbc.M008902200 Dziedzicka-Wasylewska, 2006, Fluorescence studies reveal heterodimerization of dopamine D1 and D2 receptors in the plasma membrane, Biochemistry, 45, 8751, 10.1021/bi060702m Hoffmann, 2005, A FlAsH-based FRET approach to determine G protein-coupled receptor activation in living cells, Nat Methods, 2, 171, 10.1038/nmeth742 Lohse, 2007, Monitoring receptor signaling by intramolecular FRET, Curr Opin Pharmacol, 7, 547, 10.1016/j.coph.2007.08.007 Nikolaev, 2007, Live cell monitoring of mu-opioid receptor-mediated G-protein activation reveals strong biological activity of close morphine biosynthetic precursors, J Biol Chem, 282, 27126, 10.1074/jbc.M703272200 Mercier, 2002, Quantitative assessment of beta 1- and beta 2-adrenergic receptor homo- and heterodimerization by bioluminescence resonance energy transfer, J Biol Chem, 277, 44925, 10.1074/jbc.M205767200 James, 2006, A rigorous experimental framework for detecting protein oligomerization using bioluminescence resonance energy transfer, Nat Methods, 3, 1001, 10.1038/nmeth978 Bouvier, 2007, BRET analysis of GPCR oligomerization: newer does not mean better, Nat Methods, 4, 3, 10.1038/nmeth0107-3 Salahpour, 2007, Experimental challenge to a 'rigorous' BRET analysis of GPCR oligomerization, Nat Methods, 4, 599, 10.1038/nmeth0807-599 Breit, 2004, Hetero-oligomerization between beta2- and beta3-adrenergic receptors generates a beta-adrenergic signaling unit with distinct functional properties, J Biol Chem, 279, 28756, 10.1074/jbc.M313310200 Wang, 2005, Opioid receptor homo- and heterodimerization in living cells by quantitative bioluminescence resonance energy transfer, Mol Pharmacol, 67, 2173, 10.1124/mol.104.010272 Gurevich, 2008, GPCR monomers and oligomers: it takes all kinds, Trends Neurosci, 31, 74, 10.1016/j.tins.2007.11.007 Gandia, 2008, Detection of higher-order G protein-coupled receptor oligomers by a combined BRET-BiFC technique, FEBS Lett, 582, 2979, 10.1016/j.febslet.2008.07.045 Guo, 2008, Dopamine D2 receptors form higher order oligomers at physiological expression levels, EMBO J, 27, 2293, 10.1038/emboj.2008.153 Gurevich, 2008, How and why do GPCRs dimerize?, Trends Pharmacol Sci, 29, 234, 10.1016/j.tips.2008.02.004 White, 2007, Dimerization of the class A G protein-coupled neurotensin receptor NTS1 alters G protein interaction, Proc Natl Acad Sci USA, 104, 12199, 10.1073/pnas.0705312104 Damian, 2006, Asymmetric conformational changes in a GPCR dimer controlled by G-proteins, Embo J, 25, 5693, 10.1038/sj.emboj.7601449 Bayburt, 2007, Transducin activation by nanoscale lipid bilayers containing one and two rhodopsins, J Biol Chem, 282, 14875, 10.1074/jbc.M701433200 Whorton, 2007, A monomeric G protein-coupled receptor isolated in a high-density lipo-protein particle efficiently activates its G protein, Proc Natl Acad Sci USA, 104, 7682, 10.1073/pnas.0611448104 Whorton, 2008, Efficient coupling of transducin to monomeric rhodopsin in a phospholipid bilayer, J Biol Chem, 283, 4387, 10.1074/jbc.M703346200 Ernst, 2007, Monomeric G protein-coupled receptor rhodopsin in solution activates its G protein transducin at the diffusion limit, Proc Natl Acad Sci USA, 104, 10859, 10.1073/pnas.0701967104 He, 2004, TRAF3 forms heterotrimers with TRAF2 and modulates its ability to mediate NF-{kappa}B activation, J Biol Chem, 279, 55855, 10.1074/jbc.M407284200 Carriba, 2008, Detection of heteromerization of more than two proteins by sequential BRET-FRET, Nat Methods, 5, 727, 10.1038/nmeth.1229 Fotiadis, 2003, Atomic-force microscopy: rhodopsin dimers in native disc membranes, Nature, 421, 127, 10.1038/421127a Moritz, 2001, A functional rhodopsin-green fluorescent protein fusion protein localizes correctly in transgenic Xenopus laevis retinal rods and is expressed in a time-dependent pattern, J Biol Chem, 276, 28242, 10.1074/jbc.M101476200 Agnati, 2007, A boolean network modelling of receptor mosaics relevance of topology and cooperativity, J Neural Transm, 114, 77, 10.1007/s00702-006-0567-6 Agnati, 2004, On the molecular basis of the receptor mosaic hypothesis of the engram, Cell Mol Neurobiol, 24, 501, 10.1023/B:CEMN.0000023626.35717.5d Okamoto, 1998, Expression and purification of the extracellular ligand binding region of metabotropic glutamate receptor subtype 1, J Biol Chem, 273, 13089, 10.1074/jbc.273.21.13089 Jingami, 2005, Structural and biochemical views of metabotropic glutamate receptor activation, J Mol Neurosci, 26, 123, 10.1385/JMN:26:2-3:123 Tateyama, 2004, Ligand-induced rearrangement of the dimeric metabotropic glutamate receptor 1alpha, Nat Struct Mol Biol, 11, 637, 10.1038/nsmb770 Zeng, 1999, Identification and molecular characterization of m3 muscarinic receptor dimers, J Biol Chem, 274, 19487, 10.1074/jbc.274.27.19487 Li, 2002, Human receptors for sweet and umami taste, Proc Natl Acad Sci USA, 99, 4692, 10.1073/pnas.072090199 Nelson, 2002, An amino-acid taste receptor, Nature, 416, 199, 10.1038/nature726 Nelson, 2001, Mammalian sweet taste receptors, Cell, 106, 381, 10.1016/S0092-8674(01)00451-2 Parmentier, 2002, A model for the functioning of family 3 GPCRs, Trends Pharmacol Sci, 23, 268, 10.1016/S0165-6147(02)02016-3 Guo, 2003, The fourth transmembrane segment forms the interface of the dopamine D2 receptor homodimer, J Biol Chem, 278, 4385, 10.1074/jbc.C200679200 Thummer, 2005, Entropy and oligomerization in GPCRs, J Mol Neurosci, 26, 113, 10.1385/JMN:26:2-3:113 Milligan, 2005, The specificity and molecular basis of alpha1-adrenoceptor and CXCR chemokine receptor dimerization, J Mol Neurosci, 26, 161, 10.1385/JMN:26:2-3:161 Bakker, 2004, Domain swapping in the human histamine H1 receptor, J Pharmacol Exp Ther, 311, 131, 10.1124/jpet.104.067041 Park, 2004, Oligomerization of G protein-coupled receptors: past, present, and future, Biochemistry, 43, 15643, 10.1021/bi047907k Woods, 2004, The mighty arginine, the stable quaternary amines, the powerful aromatics, and the aggressive phosphate: their role in the noncovalent minuet, J Proteome Res, 3, 478, 10.1021/pr034091l Ciruela, 2004, Combining mass spectrometry and pull-down techniques for the study of receptor heteromerization. Direct epitope-epitope electrostatic interactions between adenosine A2A and dopamine D2 receptors, Anal Chem, 76, 5354, 10.1021/ac049295f Jackson, 2006, Phosphate stabilization of intermolecular interactions, J Proteome Res, 5, 122, 10.1021/pr0503578 Agnati, 2008, Structural plasticity in G-protein coupled receptors as demonstrated by the allosteric actions of homocysteine and computer-assisted analysis of disordered domains, Brain Res Rev, 58, 459, 10.1016/j.brainresrev.2007.10.003 Haynes, 2006, Intrinsic disorder is a common feature of hub proteins from four eukaryotic interactomes, PLoS Comput Biol, 2, e100, 10.1371/journal.pcbi.0020100 Koshland, 2002, Proteomics and models for enzyme cooperativity, J Biol Chem, 277, 46841, 10.1074/jbc.R200014200 Dunker, 2005, Flexible nets. The roles of intrinsic disorder in protein interaction networks, Febs J, 272, 5129, 10.1111/j.1742-4658.2005.04948.x Han, 2004, Evidence for dynamically organized modularity in the yeast protein-protein interaction network, Nature, 430, 88, 10.1038/nature02555 Liang, 2003, Organization of the G protein-coupled receptors rhodopsin and opsin in native membranes, J Biol Chem, 278, 21655, 10.1074/jbc.M302536200 Casciari, 2006, Quaternary structure predictions of transmembrane proteins starting from the monomer: a docking-based approach, BMC Bioinformatics, 7, 340, 10.1186/1471-2105-7-340 Fanelli, 2007, Dimerization of the lutropin receptor: insights from computational modeling, Mol Cell Endocrinol, 260–262, 59, 10.1016/j.mce.2005.12.054 Dean, 2001, Dimerization of G-protein-coupled receptors, J Med Chem, 44, 4595, 10.1021/jm010290+ Raimondi, 2008, Mechanisms of inter- and intramolecular communication in GPCRs and G proteins, J Am Chem Soc, 130, 4310, 10.1021/ja077268b Franco, 2006, The two-state dimer receptor model: a general model for receptor dimers, Mol Pharmacol, 69, 1905, 10.1124/mol.105.020685 Franco, 2005, Dimer-based model for heptaspanning membrane receptors, Trends Biochem Sci, 30, 360, 10.1016/j.tibs.2005.05.010 Milligan, 2001, S 14506: novel receptor coupling at 5-HT(1A) receptors, Neuropharmacology, 40, 334, 10.1016/S0028-3908(00)00162-3 Pin, 2007, International Union of Basic and Clinical Pharmacology. LXVII. Recommendations for the recognition and nomenclature of G protein-coupled receptor heteromultimers, Pharmacol Rev, 59, 5, 10.1124/pr.59.1.5 Pin, 2005, Allosteric functioning of dimeric class C G-protein-coupled receptors, FEBS J, 272, 2947, 10.1111/j.1742-4658.2005.04728.x Rashid, 2007, Neuronal Gq/11-coupled dopamine receptors: an uncharted role for dopamine, Trends Pharmacol Sci, 28, 551, 10.1016/j.tips.2007.10.001 Rashid, 2007, D1-D2 dopamine receptor heterooligomers with unique pharmacology are coupled to rapid activation of Gq/11 in the striatum, Proc Natl Acad Sci USA, 104, 654, 10.1073/pnas.0604049104 Seeman, 1989, Link between D1 and D2 dopamine receptors is reduced in schizophrenia and Huntington diseased brain, Proc Natl Acad Sci USA, 86, 10156, 10.1073/pnas.86.24.10156 Pierce, 1998, Calcium-mediated second messengers modulate the expression of behavioral sensitization to cocaine, J Pharmacol Exp Ther, 286, 1171 Hague, 2006, Heterodimers of alpha1B- and alpha1D-adrenergic receptors form a single functional entity, Mol Pharmacol, 69, 45, 10.1124/mol.105.014985 Deighan, 2005, Insights into the functional roles of alpha(1)-adrenoceptor subtypes in mouse carotid arteries using knockout mice, Br J Pharmacol, 144, 558, 10.1038/sj.bjp.0706089 Nakata, 2005, Functions of heteromeric association between adenosine and P2Y receptors, J Mol Neurosci, 26, 233, 10.1385/JMN:26:2-3:233 Yoshioka, 2001, Heteromeric association creates a P2Y-like adenosine receptor, Proc Natl Acad Sci USA, 98, 7617, 10.1073/pnas.121587098 Kniazeff, 2004, Closed state of both binding domains of homodimeric mGlu receptors is required for full activity, Nat Struct Mol Biol, 11, 706, 10.1038/nsmb794 Carrillo, 2003, Dimers of class A G protein-coupled receptors function via agonist-mediated trans-activation of associated G proteins, J Biol Chem, 278, 42578, 10.1074/jbc.M306165200 Pascal, 2005, Functional complementation and the analysis of opioid receptor homodimerization, Mol Pharmacol, 68, 905, 10.1124/mol.105.013847 El-Asmar, 2005, Evidence for negative binding cooperativity within CCR5-CCR2b heterodimers, Mol Pharmacol, 67, 460, 10.1124/mol.104.003624 Urizar, 2005, Glycoprotein hormone receptors: link between receptor homodimerization and negative cooperativity, Embo J, 24, 1954, 10.1038/sj.emboj.7600686 Lee, 2004, Dopamine D1 and D2 receptor Co-activation generates a novel phospholipase C-mediated calcium signal, J Biol Chem, 279, 35671, 10.1074/jbc.M401923200 Anden, 1971, Hallucinogenic drugs of the indolealkylamine type and central monoamine neurons, J Pharmacol Exp Ther, 179, 236 Anden, 1968, Evidence for a central 5-hydroxytryptamine receptor stimulation by lysergic acid diethylamide, Br J Pharmacol, 34, 1, 10.1111/j.1476-5381.1968.tb07943.x Fuxe, 1976, On the biochemistry and pharmacology of hallucinogens, 135 Cummins, 1987, Chronic imipramine treatment reduces (+)2-[125I]iodolysergic acid, diethylamide but not 125I-neuropeptide Y binding in layer IV of rat cerebral cortex, Neurosci Lett, 75, 152, 10.1016/0304-3940(87)90289-8 Palacios, 1983, Quantitative receptor autoradiography: application to the study of multiple serotonin receptors in rat cortex, Adv Biochem Psychopharmacol, 37, 455 Gonzalez-Maeso, 2007, Hallucinogens recruit specific cortical 5-HT(2A) receptor-mediated signaling pathways to affect behavior, Neuron, 53, 439, 10.1016/j.neuron.2007.01.008 Gonzalez-Maeso, 2008, Identification of a serotonin/glutamate receptor complex implicated in psychosis, Nature, 452, 93, 10.1038/nature06612 Aghajanian, 2000, Serotonin model of schizophrenia: emerging role of glutamate mechanisms, Brain Res Brain Res Rev, 31, 302, 10.1016/S0165-0173(99)00046-6 Patil, 2007, Activation of mGlu2/3 receptors as a new approach to treat schizophrenia: a randomized Phase 2 clinical trial, Nat Med, 13, 1102, 10.1038/nm1632 Carriba, 2007, Striatal adenosine A2A and cannabinoid CB1 receptors form functional heteromeric complexes that mediate the motor effects of cannabinoids, Neuropsychopharmacology, 32, 2249, 10.1038/sj.npp.1301375 George, 2000, Oligomerization of mu- and delta-opioid receptors. Generation of novel functional properties, J Biol Chem, 275, 26128, 10.1074/jbc.M000345200 Salahpour, 2004, Homodimerization of the beta2-adrenergic receptor as a prerequisite for cell surface targeting, J Biol Chem, 279, 33390, 10.1074/jbc.M403363200 Zhu, 1998, Truncated V2 vasopressin receptors as negative regulators of wild-type V2 receptor function, Biochemistry, 37, 15773, 10.1021/bi981162z Benkirane, 1997, Mechanism of transdominant inhibition of CCR5-mediated HIV-1 infection by ccr5delta32, J Biol Chem, 272, 30603, 10.1074/jbc.272.49.30603 Terrillon, 2003, Oxytocin and vasopressin V1a and V2 receptors form constitutive homo- and heterodimers during biosynthesis, Mol Endocrinol, 17, 677, 10.1210/me.2002-0222 Herrick-Davis, 2006, Serotonin 5-HT2C receptor homodimer biogenesis in the endoplasmic reticulum: real-time visualization with confocal fluorescence resonance energy transfer, J Biol Chem, 281, 27109, 10.1074/jbc.M604390200 Bulenger, 2005, Emerging role of homo- and heterodimerization in G-protein-coupled receptor biosynthesis and maturation, Trends Pharmacol Sci, 26, 131, 10.1016/j.tips.2005.01.004 Franco, 2007, Receptor-receptor interactions involving adenosine A1 or dopamine D1 receptors and accessory proteins, J Neural Transm, 114, 93, 10.1007/s00702-006-0566-7 Fuxe, 2007, Adenosine receptor-dopamine receptor interactions in the basal ganglia and their relevance for brain function, Physiol Behav, 92, 210, 10.1016/j.physbeh.2007.05.034 Toda, 2003, Repeated cocaine administration changes the function and subcellular distribution of adenosine A1 receptor in the rat nucleus accumbens, J Neurochem, 87, 1478, 10.1046/j.1471-4159.2003.02121.x Scott, 2006, Allosteric changes of the NMDA receptor trap diffusible dopamine 1 receptors in spines, Proc Natl Acad Sci USA, 103, 762, 10.1073/pnas.0505557103 Lee, 2002, Dual regulation of NMDA receptor functions by direct protein-protein interactions with the dopamine D1 receptor, Cell, 111, 219, 10.1016/S0092-8674(02)00962-5 Whistler, 1999, Functional dissociation of mu opioid receptor signaling and endocytosis: implications for the biology of opiate tolerance and addiction, Neuron, 23, 737, 10.1016/S0896-6273(01)80032-5 He, 2002, Regulation of opioid receptor trafficking and morphine tolerance by receptor oligomerization, Cell, 108, 271, 10.1016/S0092-8674(02)00613-X Hillion, 2002, Coaggregation, cointernalization, and codesensitization of adenosine A2A receptors and dopamine D2 receptors, J Biol Chem, 277, 18091, 10.1074/jbc.M107731200 Torvinen, 2005, Trafficking of adenosine A2A and dopamine D2 receptors, J Mol Neurosci, 25, 191, 10.1385/JMN:25:2:191 Yesilaltay, 2000, Homo-oligomeric complexes of the yeast alpha-factor pheromone receptor are functional units of endocytosis, Mol Biol Cell, 11, 2873, 10.1091/mbc.11.9.2873 Rocheville, 2000, Subtypes of the somatostatin receptor assemble as functional homo- and heterodimers, J Biol Chem, 275, 7862, 10.1074/jbc.275.11.7862 Angers, 2000, Detection of beta 2-adrenergic receptor dimerization in living cells using bioluminescence resonance energy transfer (BRET), Proc Natl Acad Sci USA, 97, 3684 Cornea, 2001, Gonadotropin-releasing hormone receptor microaggregation. Rate monitored by fluorescence resonance energy transfer, J Biol Chem, 276, 2153, 10.1074/jbc.M007850200 Kroeger, 2001, Constitutive and agonist-dependent homo-oligomerization of the thyrotropin-releasing hormone receptor. Detection in living cells using bioluminescence resonance energy transfer, J Biol Chem, 276, 12736, 10.1074/jbc.M011311200 Cheng, 2001, Agonist-dependent dissociation of oligomeric complexes of G protein-coupled cholecystokinin receptors demonstrated in living cells using bioluminescence resonance energy transfer, J Biol Chem, 276, 48040, 10.1074/jbc.M105668200 Overton, 2002, Use of fluorescence resonance energy transfer to analyze oligomerization of G-protein-coupled receptors expressed in yeast, Methods, 27, 324, 10.1016/S1046-2023(02)00090-7 Ghanouni, 2001, Agonist-induced conformational changes in the G-protein-coupling domain of the beta 2 adrenergic receptor, Proc Natl Acad Sci USA, 98, 5997, 10.1073/pnas.101126198 Ayoub, 2002, Monitoring of ligand-independent dimerization and ligand-induced conformational changes of melatonin receptors in living cells by bioluminescence resonance energy transfer, J Biol Chem, 277, 21522, 10.1074/jbc.M200729200 Ayoub, 2004, Preferential formation of MT1/MT2 melatonin receptor heterodimers with distinct ligand interaction properties compared with MT2 homodimers, Mol Pharmacol, 66, 312, 10.1124/mol.104.000398 Springael, 2006, Allosteric modulation of binding properties between units of chemokine receptor homo- and heterooligomers, Mol Pharmacol, 69, 1652, 10.1124/mol.105.019414 Springael, 2005, Dimerization of chemokine receptors and its functional consequences, Cytokine Growth Factor Rev, 16, 611, 10.1016/j.cytogfr.2005.05.005 Mellado, 2001, Chemokine receptor homo- or heterodimerization activates distinct signaling pathways, Embo J, 20, 2497, 10.1093/emboj/20.10.2497 Agnati, 2008, Receptor mosaics of neural and immune communication: possible implications for basal ganglia functions, Brain Res Rev, 58, 400, 10.1016/j.brainresrev.2007.10.002 Fuxe, 2008, A new road to neuroinflammation in Parkinson's disease?, Brain Res Rev, 58, 453, 10.1016/j.brainresrev.2008.04.003 Goncharova, 2007, Molecular networks of brain and immunity, Brain Res Rev, 55, 155, 10.1016/j.brainresrev.2007.02.003 Goncharova, 2008, Nanotubes at neural and immune synapses, Curr Med Chem, 15, 210, 10.2174/092986708783497265 Agnati, 2007, Possible relevance of receptor-receptor interactions between viral- and host-coded receptors for viral-induced disease, SWJ, 7, 1073 Lipton, 1997, Neurotoxicity associated with dual actions of homocysteine at the N-methyl-D-aspartate receptor, Proc Natl Acad Sci USA, 94, 5923, 10.1073/pnas.94.11.5923 Agnati, 2006, Allosteric modulation of dopamine D2 receptors by homocysteine, J Proteome Res, 5, 3077, 10.1021/pr0601382 Agnati, 2008, Structural plasticity in G-protein coupled receptors as demonstrated by the allosteric actions of homocysteine and computer-assisted analysis of disordered domains, Brain Res Rev, 58, 459, 10.1016/j.brainresrev.2007.10.003 Fuxe, 2005, Adenosine A2A and dopamine D2 heteromeric receptor complexes and their function, J Mol Neurosci, 26, 209, 10.1385/JMN:26:2-3:209 Fuxe, 2007, Adenosine A(2A) receptors, dopamine D(2) receptors and their interactions in Parkinson's disease, Mov Disord, 22, 1990, 10.1002/mds.21440 Schwarzschild, 2006, Targeting adenosine A2A receptors in Parkinson's disease, Trends Neurosci, 29, 647, 10.1016/j.tins.2006.09.004 Bockaert, 2004, GPCR interacting proteins (GIP), Pharmacol Ther, 103, 203, 10.1016/j.pharmthera.2004.06.004 Bockaert, 2003, The 'magic tail' of G protein-coupled receptors: an anchorage for functional protein networks, FEBS Lett, 546, 65, 10.1016/S0014-5793(03)00453-8 Ciruela, 2005, Heptaspanning membrane receptors and cytoskeletal/scaffolding proteins: focus on adenosine, dopamine, and metabotropic glutamate receptor function, J Mol Neurosci, 26, 277, 10.1385/JMN:26:2-3:277 Franco, 2003, Regulation of heptaspanning-membrane-receptor function by dimerization and clustering, Trends Biochem Sci, 28, 238, 10.1016/S0968-0004(03)00065-3 Lin, 2001, Dopamine D2 and D3 receptors are linked to the actin cytoskeleton via interaction with filamin A, Proc Natl Acad Sci USA, 98, 5258, 10.1073/pnas.011538198 Burgueno, 2003, The adenosine A2A receptor interacts with the actin-binding protein alpha-actinin, J Biol Chem, 278, 37545, 10.1074/jbc.M302809200 Vetter, 2003, Novel aspects of calmodulin target recognition and activation, Eur J Biochem, 270, 404, 10.1046/j.1432-1033.2003.03414.x Bofill-Cardona, 2000, Binding of calmodulin to the D2-dopamine receptor reduces receptor signaling by arresting the G protein activation switch, J Biol Chem, 275, 32672, 10.1074/jbc.M002780200 Terasmaa, 2003 Liu, 2007, Evidence that calmodulin binding to the dopamine D2 receptor enhances receptor signaling, J Recept Signal Transduct Res, 27, 47, 10.1080/10799890601094152 Torvinen, 2004, Biochemical identification of the dopamine D2 receptor domains interacting with the adenosine A2A receptor, J Mol Neurosci, 24, 173, 10.1385/JMN:24:2:173 Ferre, 2007, Heteromerization of G-protein-coupled receptors. Implications for central nervous system function and dysfunction, SWJ, 7, 46 Woods A, Marcellino D, Jackson SN, et al. How calmodulin interacts with the adenosine A2A and the dopamine D2 receptors. J Proteome Res 2008; [in press]. Bunnemann, 1990, Autoradiographic localization of mas proto-oncogene mRNA in adult rat brain using in situ hybridization, Neurosci Lett, 114, 147, 10.1016/0304-3940(90)90063-F Bunnemann, 1991, The brain reninangiotensin system and its possible involvement in volume transmission, 131 Ambroz, 1991, The mas oncogene enhances angiotensin-induced [Ca2+]i responses in cells with preexisting angiotensin II receptors, Biochim Biophys Acta, 1133, 107, 10.1016/0167-4889(91)90248-V Von Bohlen und Halbach, 2000, Interaction between Mas and the angiotensin AT1 receptor in the amygdala, J Neurophysiol, 83, 2012, 10.1152/jn.2000.83.4.2012 Kostenis, 2005, G-protein-coupled receptor Mas is a physiological antagonist of the angiotensin II type 1 receptor, Circulation, 111, 1806, 10.1161/01.CIR.0000160867.23556.7D Fior, 1993, Autoradiographic evidence for a bradykinin/angiotensin II receptor-receptor interaction in the rat brain, Neurosci Lett, 163, 58, 10.1016/0304-3940(93)90228-D AbdAlla, 2001, Increased AT(1) receptor heterodimers in preeclampsia mediate enhanced angiotensin II responsiveness, Nat Med, 7, 1003, 10.1038/nm0901-1003 AbdAlla, 2005, Mesangial AT1/B2 receptor heterodimers contribute to angiotensin II hyperresponsiveness in experimental hypertension, J Mol Neurosci, 26, 185, 10.1385/JMN:26:2-3:185 Franco, 1997, Cell surface adenosine deaminase: much more than an ectoenzyme, Prog Neurobiol, 52, 283, 10.1016/S0301-0082(97)00013-0 Ciruela, 1996, Adenosine deaminase affects ligand-induced signalling by interacting with cell surface adenosine receptors, FEBS Lett, 380, 219, 10.1016/0014-5793(96)00023-3 Agnati, 2007, The brain as a system of nested but partially overlapping networks. Heuristic relevance of the model for brain physiology and pathology, J Neural Transm, 114, 3, 10.1007/s00702-006-0563-x Fuxe, 2007, From the Golgi-Cajal mapping to the transmitter-based characterization of the neuronal networks leading to two modes of brain communication: wiring and volume transmission, Brain Res Rev, 55, 17, 10.1016/j.brainresrev.2007.02.009 Daniels, 2005, Opioid-induced tolerance and dependence in mice is modulated by the distance between pharmacophores in a bivalent ligand series, Proc Natl Acad Sci USA, 102, 19208, 10.1073/pnas.0506627102 Waldhoer, 2005, A heterodimer-selective agonist shows in vivo relevance of G protein-coupled receptor dimers, Proc Natl Acad Sci USA, 102, 9050, 10.1073/pnas.0501112102 Daniels, 2005, A bivalent ligand (KDAN-18) containing delta-antagonist and kappa-agonist pharmacophores bridges delta2 and kappa1 opioid receptor phenotypes, J Med Chem, 48, 1713, 10.1021/jm034234f Xie, 2005, Interaction of bivalent ligand KDN21 with heterodimeric delta-kappa opioid receptors in human embryonic kidney 293 cells, Mol Pharmacol, 68, 1079, 10.1124/mol.105.012070 Liu, 2000, Direct protein-protein coupling enables cross-talk between dopamine D5 and gamma-aminobutyric acid A receptors, Nature, 403, 274, 10.1038/35001232 Lee, 2005, Direct receptor cross-talk can mediate the modulation of excitatory and inhibitory neurotransmission by dopamine, J Mol Neurosci, 26, 245, 10.1385/JMN:26:2-3:245 Fiorentini, 2003, Regulation of dopamine D1 receptor trafficking and desensitization by oligomerization with glutamate N-methyl-D-aspartate receptors, J Biol Chem, 278, 20196, 10.1074/jbc.M213140200 Liu, 2006, Modulation of D2R-NR2B interactions in response to cocaine, Neuron, 52, 897, 10.1016/j.neuron.2006.10.011 Hackel, 1999, Epidermal growth factor receptors: critical mediators of multiple receptor pathways, Curr Opin Cell Biol, 11, 184, 10.1016/S0955-0674(99)80024-6 Luttrell, 1999, Regulation of tyrosine kinase cascades by G-protein-coupled receptors, Curr Opin Cell Biol, 11, 177, 10.1016/S0955-0674(99)80023-4 Luttrell, 1997, Gbetagamma subunits mediate Src-dependent phosphorylation of the epidermal growth factor receptor. A scaffold for G protein-coupled receptor-mediated Ras activation, J Biol Chem, 272, 4637, 10.1074/jbc.272.7.4637 Lefkowitz, 2005, Transduction of receptor signals by beta-arrestins, Science, 308, 512, 10.1126/science.1109237 Lee, 2001, Activation of Trk neurotrophin receptors in the absence of neurotrophins, Proc Natl Acad Sci USA, 98, 3555, 10.1073/pnas.061020198 Lee, 2002, Distinctive features of Trk neurotrophin receptor transactivation by G protein-coupled receptors, Cytokine Growth Factor Rev, 13, 11, 10.1016/S1359-6101(01)00024-7 Lowes, 2002, Integration of signals from receptor tyrosine kinases and g protein-coupled receptors, Neurosignals, 11, 5, 10.1159/000057317 Luttrell, 2002, Activation and targeting of mitogen-activated protein kinases by G-protein-coupled receptors, Can J Physiol Pharmacol, 80, 375, 10.1139/y02-045 Marinissen, 2001, G-protein-coupled receptors and signaling networks: emerging paradigms, Trends Pharmacol Sci, 22, 368, 10.1016/S0165-6147(00)01678-3 Wang, 2005, Dopamine D2 receptor stimulation of mitogen-activated protein kinases mediated by cell type-dependent transactivation of receptor tyrosine kinases, J Neurochem, 93, 899, 10.1111/j.1471-4159.2005.03055.x Flajolet, 2008, FGF as a co-transmitter through adenosine A2A receptor to regulate synaptic plasticity, Nature Neuroscience, 11, 1402, 10.1038/nn.2216 Ferre, 2007, Functional relevance of neurotransmitter receptor heteromers in the central nervous system, Trends Neurosci, 30, 440, 10.1016/j.tins.2007.07.001